In a subsequent study aimed at increasing the tumor‐targeting ability for epidermal growth factor receptor (EGFR)‐expressing colorectal cancer, a recombinant protein (anti‐EGFR‐iRGD), harboring the EGFR antibody and the iRGD peptide, was functionalized on the surface of gambogic acid‐loaded PLGA NPs coated with red blood cell membranes.94 Here, EGFR is linked to neoplasm.